IMDK (quarterhydrate)
IMDK quarterhydrate is a potent PI3K inhibitor and inhibits the growth factor MDK (also known as midkine or MK) . iMDK quarterhydrate suppresses non-small cell lung cancer (NSCLC) cooperatively with A MEK inhibitor without harming normal cells and mice[1].
Product Specifications
UNSPSC
12352005
Target
PI3K
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/imdk-quarterhydrate.html
Purity
99.37
Solubility
DMSO : 3.33 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1C(C2=CN3C(SC(CC4=CC=C(F)C=C4)=C3)=N2)=CC5=CC=CC=C5O1.O
Molecular Formula
C21H13FN2O2S.1/4H2O
Molecular Weight
380.91
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Citation 01
Nat Commun. 2023 Jul 31;14 (1) :4600.|Cell Discov. 2024 Oct 22;10 (1) :110.|IUBMB Life. 2025 May;77 (5) :e70014.
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TGIF2LX, ID (TGIF2LX, TGIFLX, Homeobox protein TGIF2LX, TGF-beta-induced transcription factor 2-like protein, TGFB-induced factor 2-like protein, X-linked, TGIF-like on the X) (Biotin) discontinued
Recombinant Xenopus laevis Homeobox protein vex1 (vex1)
Recombinant Xenopus laevis Homeobox protein vex1 (vex1)
Recombinant Xenopus laevis Homeobox protein vex1 (vex1)
Recombinant Xenopus laevis Homeobox protein vex1 (vex1)